NEPAL > India based Tizig Pharma is set to invest Rs 351 million ($3.4 million) in cancer drug plant in Bhaktapur, Nepal

Tizig Pharma Pvt. Ltd. is set to invest Rs 351 million ($3.4 million) in Nepal for cancer drug production plant. As the cancer patients have increased in recent years, the India based company is set to invest in Nepal. Venkatesham Ambati, an Indian citizen, is the sole investor of the project. According to Khagendra Basnet, Director of the Department of More …